Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Franklin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Insulin-like growth factor 1 enhances renal function in a patient with chronic renal failure on peritoneal dialysisA Vijayan, S C Franklin, J A Delmez, et al.
Epilepsia|March 1, 1976
Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Fourth-month follow-up period: seizure, EEG, blood and behavioral dataJ S Lockard, L L DuCharme, W C Congdon, et al.
The American Journal of Physiology|April 13, 1999
Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failureA Vijayan, S C Franklin, T Behrend, et al.
The American Journal of Physiology|February 1, 1997
Insulin-like growth factor I preserves renal function postoperativelyS C Franklin, M Moulton, G A Sicard, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 21, 1998
Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiencyS Dagogo-Jack, S C Franklin, A Vijayan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Insulin-like growth factor 1 enhances renal function in a patient with chronic renal failure on peritoneal dialysisA Vijayan, S C Franklin, J A Delmez, et al.
Epilepsia|March 1, 1976
Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Fourth-month follow-up period: seizure, EEG, blood and behavioral dataJ S Lockard, L L DuCharme, W C Congdon, et al.
The American Journal of Physiology|April 13, 1999
Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failureA Vijayan, S C Franklin, T Behrend, et al.
The American Journal of Physiology|February 1, 1997
Insulin-like growth factor I preserves renal function postoperativelyS C Franklin, M Moulton, G A Sicard, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 21, 1998
Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiencyS Dagogo-Jack, S C Franklin, A Vijayan, et al.
Pageof 1